Cash advance, indicating a strong confidence in SPR's technical roadmap

View Original
MarsBitNews
Medtronic plans to pay approximately $650 million in cash to acquire SPR Therapeutics.
Mars Finance News May 20 – Medtronic plans to pay approximately $650 million in cash to acquire SPR Therapeutics, expanding treatment options for chronic pain patients. (Wide-angle observation)
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned